The bill was sponsored by Reps. Terri Sewell, D-Ala., Adrian Smith, R-Neb., Tony Cárdenas, D-Calif., and John Shimkus, R-Ill.
“There is bipartisan agreement and recognition that, without additional guardrails and transparency, patient care could be compromised by even a well-intentioned experimental model,” Mr. Shimkus said in a press release. “This legislation would help ensure the CMMI functions as Congress intended, with protections for both patients and providers.”
The Strengthening Innovation in Medicare and Medicaid Act creates safeguards around CMMI by, among other provisions, outlining a way for Congress to fast-track disapproval of a payment model, creating more ways for the public to provide input, and requiring more input and collaboration from experts on the needs of underrepresented patient groups.
“The legislation we introduced today would safeguard the Center from implementing politically-driven or other policy changes made unilaterally by any administration that could be harmful to patients and providers,” Ms. Sewell said in the press release.
More articles on innovation:
Verily launches joint venture for ophthalmology innovation
HBR: 5 keys to success when crowdsourcing innovation
10 Arkansas providers recruit startups for 2nd annual digital health accelerator
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
